To investigate the molecular mechanisms underlying this differential requirement of RAF kinases at different stages of melanomagenesis, we used in situ proximity ligation assays (PLA) to look at the ability of endogenous BRAF and CRAF to interact with NRAS first in cells from full-blown melanoma. Here, RAF1 is linked to melanoma.